125 related articles for article (PubMed ID: 9357407)
1. Hormone replacement therapy and risk of non-fatal stroke.
Pedersen AT; Lidegaard O; Kreiner S; Ottesen B
Lancet; 1997 Nov; 350(9087):1277-83. PubMed ID: 9357407
[TBL] [Abstract][Full Text] [Related]
2. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1996 Aug; 348(9026):505-10. PubMed ID: 8757152
[TBL] [Abstract][Full Text] [Related]
3. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
Beresford SA; Weiss NS; Voigt LF; McKnight B
Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
5. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1996 Aug; 348(9026):498-505. PubMed ID: 8757151
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and risk of glioma: a nationwide nested case-control study.
Andersen L; Friis S; Hallas J; Ravn P; Gaist D
Cancer Epidemiol; 2013 Dec; 37(6):876-80. PubMed ID: 24138870
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy increases the risk of cranial meningioma.
Andersen L; Friis S; Hallas J; Ravn P; Schrøder HD; Gaist D
Eur J Cancer; 2013 Oct; 49(15):3303-10. PubMed ID: 23800670
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and hormone-replacement therapy in the Million Women Study.
Beral V;
Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and risk of myocardial infarction: a national register study.
Løkkegaard E; Andreasen AH; Jacobsen RK; Nielsen LH; Agger C; Lidegaard Ø
Eur Heart J; 2008 Nov; 29(21):2660-8. PubMed ID: 18826989
[TBL] [Abstract][Full Text] [Related]
12. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
Beral V; Banks E; Reeves G
Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
[TBL] [Abstract][Full Text] [Related]
13. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
Renoux C; Dell'aniello S; Garbe E; Suissa S
BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
[TBL] [Abstract][Full Text] [Related]
14. Myocardial infarction risk and hormone replacement: differences between products.
de Vries CS; Bromley SE; Farmer RD
Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism in users of hormone replacement therapy.
Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
[TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular risk and hormone replacement therapy in menopause].
Plu-Bureau G
Therapie; 1999; 54(3):375-80. PubMed ID: 10500454
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and stroke risk in older women.
Fung MM; Barrett-Connor E; Bettencourt RR
J Womens Health; 1999 Apr; 8(3):359-64. PubMed ID: 10326990
[TBL] [Abstract][Full Text] [Related]
18. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort.
Finucane FF; Madans JH; Bush TL; Wolf PH; Kleinman JC
Arch Intern Med; 1993 Jan; 153(1):73-9. PubMed ID: 8422201
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study.
Løkkegaard E; Jovanovic Z; Heitmann BL; Keiding N; Ottesen B; Hundrup YA; Obel EB; Pedersen AT
Arch Neurol; 2003 Oct; 60(10):1379-84. PubMed ID: 14568807
[TBL] [Abstract][Full Text] [Related]
20. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
Jick H; Derby LE; Myers MW; Vasilakis C; Newton KM
Lancet; 1996 Oct; 348(9033):981-3. PubMed ID: 8855853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
